Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 4, 2007, Pages 1020-1032

  Schneider, Günther ^a   Ballarati, Claudio ^b   Grazioli, Luigi ^c   Manfredi, Riccardo ^d   Thurnher, Siegfried ^e   Kroencke, Thomas J ^f   Taupitz, Matthias ^f   Merlino, Biagio ^g   Bonomo, Lorenzo ^g   Shen, Ningyan ^h   Pirovano, Gianpaolo ^h   Kirchin, Miles A ⁱ   Spinazzi, Alberto ^h,i  

^a SAARLAND UNIVERSITY   (Germany)

^b VALDUCE HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e Hospital Brothers of St John of God   (Austria)

^f HUMBOLDT UNIVERSITY   (Germany)

^g UNIVERSITY OF CHIETI   (Italy)

^h Bracco Research USA   (United States)

ⁱ Bracco Imaging SpA   (Italy)

Author keywords

Contrast agents; Diagnostic performance; Dose finding studies; Gadobenate dimeglumine; MR angiography; Steno occlusive disease

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CHI SQUARE TEST; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG DOSE COMPARISON; FEMALE; HUMAN; ILIAC ARTERY OBSTRUCTION; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AORTIC VALVE STENOSIS; CAROTID STENOSIS; CONSTRICTION, PATHOLOGIC; CONTRAST MEDIA; FEMALE; HUMANS; ILIAC ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; RENAL ARTERY OBSTRUCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 35148891818     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21127     Document Type: Article

References (70)

1. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
2. de Haën C, Cabrini M, Akhnana L, et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999;23(Suppl 1):S161-S168.
3. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006;41:213-221. Erratum, Invest Radiol 2006;41:859.
4. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
5. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest Radiol 2006;41:222-228.
6. Knopp MV, Runge VM, Essig M, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004;230:55-64.
7. Colosimo C, Knopp MV, Barreau X, et al. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours. Neuroradiology 2004;46:655-665.
8. Colosimo C, Demaerel P, Tortori-Donati P, et al. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in pediatric subjects. Pediatr Radiol 2005;35:501-510.
9. Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 2006;240:389-400.
10. Kuhn MJ, Picozzi P, Maldjian JA, et al. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention. J Neurosurg 2007;106:557-566.
11. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography: phase 1 studies. Invest Radiol 2002;37:706-715.
12. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17:694-702.
13. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220:484-488.
14. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A. Prospective blinded evaluation of Gd-DOTA-versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003;227:261-269.
15. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005;234:399-408.
16. Pediconi F, Fraioli F, Catalano C, et al. Gadobenate dimeglumine (Gd-BOPTA) vs. gadopentetate dimeglumine (Gd-DTPA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio. Radiol Med (Torino) 2003;106:87-93.
17. Wikström J, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine - enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 2003;38:504-515.
18. Kroencke TJ, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 2002;179:1573-1582.
19. Merlino B, Hentrich H-R, Daprà M, Kirchin MA, Bonomo L. Gadobenate dimeglumine in contrast enhanced magnetic resonance angiography of the carotid arteries. Presented at the 9th meeting of the Int Soc Magn Reson Med and the 18th meeting of the Eur Soc Magn Reson Med Biol; joint meeting Glasgow, Scotland. In: Proc ISMRM 2001:1916 (Abstract).
20. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001;357:1086-1091.
21. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 2002;224:270-277.
22. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135:401-411.
23. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
25. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons; 1981.
26. Hany TF, Debatin JF, Leung DA, et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
27. Wikström J, Holmberg A, Johansson L, et al. Gadolinium-enhanced magnetic resonance angiography, digital subtraction angiography and duplex of the iliac arteries compared with intra-arterial pressure gradient measurements. Eur J Vasc Endovasc Surg 2000;19:516-523.
28. Willig DS, Turski PA, Frayne R, et al. Contrast-enhanced 3D MR DSA of the carotid artery bifurcation: preliminary study of comparison with unenhanced 2D and 3D time-of-flight MR angiography. Radiology 1998;208:447-451.
29. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995;196:371-378.
30. Parker DL, Tsuruda JS, Goodrich KC, et al. Contrast-enhanced magnetic resonance angiography of cerebral arteries: a review. Invest Radiol 1998;33:560-572.
31. Lorenz CH, Johansson LO. Contrast-enhanced coronary MRA. J Magn Reson Imaging 1999;10:703-708.
32. Michaely HJ, Nael K, Schoenberg SO, et al. The feasibility of spatial high-resolution magnetic resonance angiography (MRA) of the renal arteries at 3.0 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2005;177:800-804.
33. Schoenberg SO, Rieger J, Weber CH, et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology 2005;235:687-698.
34. Serfaty JM, Chirossel P, Chevallier JM, Ecochard R, Froment JC, Douek PC. Accuracy of three-dimensional gadolinium-enhanced MR angiography in the assessment of extracranial carotid artery disease. AJR Am J Roentgenol 2000;175:455-463.
35. Huston J 3rd, Fain SB, Wald JT, et al. Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography. Radiology 2001;218:138-143.
36. Fellner FA, Fellner C, Wutke R, et al. Fluoroscopically triggered contrast-enhanced 3D MR DSA and 3D time-of-flight turbo MRA of the carotid arteries: first clinical experiences in correlation with ultrasound, x-ray angiography, and endarterectomy findings. Magn Reson Imaging 2000;18:575-585.
37. Remonda L, Senn P, Barth A, Arnold M, Lovblad KO, Schroth G. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol 2002;23:213-219.
38. Borisch I, Horn M, Butz B, et al. Preoperative evaluation of carotid artery stenosis: comparison of contrast-enhanced MR angiography and duplex sonography with digital subtraction angiography. AJNR Am J Neuroradiol 2003;24:1117-1122.
39. Alvarez-Linera J, Benito-Leon J, Escribano J, Campollo J, Gesto R. Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol 2003;24:1012-1019.
40. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
41. Schoenberg SO, Bock M, Knopp MV, et al. Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing- independent fast multiphase acquisition in a single breath hold. Radiology 1999;211:667-679.
42. Bongers V, Bakker J, Beutler JJ, Beek FJ, De Klerk JM. Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol 2000;55:346-353.
43. Mittal TK, Evans C, Perkins T, Wood AM. Renal arteriography using gadolinium enhanced 3D MR angiography - clinical experience with the technique, its limitations and pitfalls. Br J Radiol 2001;74:495-502.
44. Gilfeather M, Yoon H-C, Siegelman ES, et al. Renal artery stenosis: evaluation with conventional angiography versus gadolinium-enhanced MR angiography. Radiology 1999;210:367-372.
45. Fain SB, King BF, Breen JF, Kruger DG, Riederer SJ. High-spatial- resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001;218:481-490.
46. Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998;16:901-906.
47. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 2000;174:1127-1135.
48. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology 2003;226:798-811.
49. Venkataraman S, Semelka RC, Weeks S, Braga L, Vaidean G. Assessment of aorto-iliac disease with magnetic resonance angiography using arterial phase 3-D gradient-echo and interstitial phase 2-D fat-suppressed spoiled gradient-echo sequences. J Magn Reson Imaging 2003;17:43-53.
50. Anzalone N, Scomazzoni F, Castellano R, et al. Carotid artery stenosis: intraindividual correlations of 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading. Radiology 2005;236:204-213.
51. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
52. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
53. Pedersen M. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;25:881-883.
54. Kirchin MA, Runge VM. Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging 2003;14:426-435.
55. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006;1:128-137.
56. Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007;25:884-899.
57. Schneider G, Kirchin MA, Pirovano G, et al. Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation. J Magn Reson Imaging 2001;14:525-539.
58. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
59. Nederkoorn PJ, Elgersma OE, van der Graaf Y, Eikelboom BC, Kappelle LJ, Mali WP. Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology 2003;228:677-682.
60. Wilson GJ, Hoogeveen RM, Willinek WA, Muthupillai R, Maki JH. Parallel imaging in MR angiography. Top Magn Reson Imaging 2004;15:169-185.
61. Wilson GJ, Eubank WB, Vasbinder GB, et al. Utilizing SENSE to reduce scan duration in high-resolution contrast-enhanced renal MR angiography. J Magn Reson Imaging 2006;24:873-879.
62. Hany TF, Carroll TJ, Omary RA, et al. Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography - initial results. Radiology 2001;221:266-272.
63. Janka R, Fellner C, Wenkel E, Lang W, Bautz W, Fellner FA. Contrast-enhanced MR angiography of peripheral arteries including pedal vessels at 1.0 T: feasibility study with dedicated peripheral angiography coil. Radiology 2005;235:319-326.
64. Wutke R, Lang W, Fellner C, et al. High-resolution, contrast-enhanced magnetic resonance angiography with elliptical centric k-space ordering of supra-aortic arteries compared with selective X-ray angiography. Stroke 2002;33:1522-1529.
65. Willinek WA, von Falkenhausen M, Born M, et al. Noninvasive detection of steno-occlusive disease of the supra-aortic arteries with three-dimensional contrast-enhanced magnetic resonance angiography: a prospective, intra-individual comparative analysis with digital subtraction angiography. Stroke 2005;36:38-43.
66. Goyen M, Herborn CU, Lauenstein TC, et al. Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography. Invest Radiol 2002;37:263-268.
67. Goyen M, Herborn CU, Kroger K, Lauenstein TC, Debatin JF, Ruehm SG. Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography - initial experience. Radiology 2003;227:277-282.
68. Kirchin MA, Pirovano G, Venetianer C, Spinazzi A. Safety assessment of gadobenate dimeglumine (Multihance): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging 2001;14:281-294.
69. Shellock FG, Parker JR, Venetianer C, Pirovano G, Spinazzi A. Safety of gadobenate dimeglumine: summary of findings from clinical studies and post-marketing surveillance. Invest Radiol 2006;41:500-509.
70. Shellock FG, Parker JR, Pirovano G, et al. Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and inter-individual comparison studies with gadopentetate dimeglumine. J Magn Reson Imaging 2006;24:1378-1385.